Bacterial lipodipeptide, Lipid 654, is a microbiome‐associated biomarker for multiple sclerosis V Farrokhi, R Nemati, FC Nichols, X Yao, E Anstadt, M Fujiwara, J Grady, ... Clinical & translational immunology 2 (11), e8, 2013 | 98 | 2013 |
MicroRNA-146a limits tumorigenic inflammation in colorectal cancer LP Garo, AK Ajay, M Fujiwara, G Gabriely, R Raheja, C Kuhn, B Kenyon, ... Nature communications 12 (1), 2419, 2021 | 80 | 2021 |
Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands RB Clark, JL Cervantes, MW Maciejewski, V Farrokhi, R Nemati, X Yao, ... Infection and immunity 81 (9), 3479-3489, 2013 | 76 | 2013 |
Smad7 controls immunoregulatory PDL2/1-PD1 signaling in intestinal inflammation and autoimmunity LP Garo, AK Ajay, M Fujiwara, V Beynon, C Kuhn, G Gabriely, ... Cell reports 28 (13), 3353-3366. e5, 2019 | 47 | 2019 |
TLR tolerance as a treatment for central nervous system autoimmunity EJ Anstadt, M Fujiwara, N Wasko, F Nichols, RB Clark The Journal of Immunology 197 (6), 2110-2118, 2016 | 42 | 2016 |
Enhanced TLR2 responses in multiple sclerosis M Fujiwara, EJ Anstadt, B Flynn, K Morse, C Ng, P Paczkowski, J Zhou, ... Clinical & Experimental Immunology 193 (3), 313-326, 2018 | 33 | 2018 |
Cbl-b deficiency mediates resistance to programmed death-ligand 1/programmed death-1 regulation M Fujiwara, EJ Anstadt, RB Clark Frontiers in Immunology 8, 235438, 2017 | 32 | 2017 |
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance M Fujiwara, R Raheja, LP Garo, AK Ajay, R Kadowaki-Saga, ... The Journal of clinical investigation 132 (10), 2022 | 20 | 2022 |
Deletion of STAT3 from Foxd1 cell population protects mice from kidney fibrosis by inhibiting pericytes trans-differentiation and migration AK Ajay, L Zhao, S Vig, M Fujiwara, S Thakurela, S Jadhav, A Cho, ... Cell reports 38 (10), 2022 | 19 | 2022 |
Regulation of splenic monocyte homeostasis and function by gut microbial products P Kolypetri, S Liu, LM Cox, M Fujiwara, R Raheja, D Ghitza, A Song, ... Iscience 24 (4), 2021 | 9 | 2021 |
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720 M Fujiwara, EJ Anstadt, KM Khanna, RB Clark Clinical Immunology 158 (1), 103-113, 2015 | 9 | 2015 |
Treatment of experimental autoimmune encephalomyelitis with an inhibitor of phosphodiesterase-8 (PDE8) CP Basole, RK Nguyen, K Lamothe, P Billis, M Fujiwara, AG Vang, ... Cells 11 (4), 660, 2022 | 5 | 2022 |
Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells G Gabriely, D Ma, S Siddiqui, L Sun, NP Skillin, H Abou-El-Hassan, ... Iscience 24 (11), 2021 | 5 | 2021 |
Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector RC Guayasamin, TD Reynolds, X Wei, M Fujiwara, MD Robek Journal of Virology 88 (18), 10909-10917, 2014 | 4 | 2014 |
Cbl-b deficiency renders T cells resistant to PD-L1/PD-1 mediated suppression M Fujiwara, EJ Anstadt, RB Clark The Journal of Immunology 196 (1_Supplement), 55.22-55.22, 2016 | 3 | 2016 |
PD1 blockade in cancer: impact on myeloid cells M Fujiwara, LP Garo, G Murugaiyan Trends in Cancer 6 (6), 443-444, 2020 | 2 | 2020 |
Effects of mono-and dialkylglucosides on the characterisation and blood circulation of lipid nanoemulsions S Takegami, A Konishi, S Okazaki, M Fujiwara, T Kitade Journal of Microencapsulation 36 (8), 738-746, 2019 | 2 | 2019 |
Remyelination-Promoting Inflammation: Novel Role for MyD88 Signaling in Microglia/Macrophages G Murugaiyan, M Fujiwara, LP Garo Trends in Neurosciences 43 (7), 455-457, 2020 | 1 | 2020 |
TLR2 tolerance in EAE EJ Anstadt, M Fujiwara, F Nichols, RB Clark The Journal of Immunology 196 (1_Supplement), 118.12-118.12, 2016 | 1 | 2016 |
O004 Using type III interferon to improve the efficacy of vaccine and oncolytic viral vectors TD Reynolds, RC Guayasamin, M Fujiwara, MD Robek Cytokine 59 (3), 498, 2012 | 1 | 2012 |